FRED HUTCHINSON CANCER CENTER
🇺🇸United States
Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 138
- Registration Number
- NCT06026371
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Phase 2
Recruiting
- Conditions
- Acute Leukemia of Ambiguous LineageAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaBlastic Plasmacytoid Dendritic Cell NeoplasmHematopoietic and Lymphoid System NeoplasmMixed Phenotype Acute LeukemiaMyelodysplastic SyndromeMyeloproliferative NeoplasmNon-Hodgkin LymphomaChronic Myeloid Leukemia, BCR-ABL1 Positive
- Interventions
- Procedure: Biospecimen CollectionProcedure: Bone Marrow AspirateDrug: CyclophosphamideDrug: CyclosporineProcedure: Diagnostic ImagingProcedure: EchocardiographyDrug: Fludarabine PhosphateProcedure: Multigated Acquisition ScanDrug: Mycophenolate MofetilOther: Survey AdministrationDrug: ThiotepaRadiation: Total-Body IrradiationProcedure: Umbilical Cord Blood Transplantation
- First Posted Date
- 2023-08-28
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 54
- Registration Number
- NCT06013423
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-18
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 82
- Registration Number
- NCT05996627
- Locations
- 🇺🇸
Mass General Cancer Center, Boston, Massachusetts, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
IVIG for Infection Prevention After CAR-T-Cell Therapy
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 150
- Registration Number
- NCT05952804
- Locations
- 🇺🇸
City of Hope Cancer Center, Duarte, California, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy
Phase 1
Withdrawn
- Conditions
- Interventions
- Biological: Interferon Beta-1AProcedure: X-Ray ImagingProcedure: EchocardiographyProcedure: Multigated Acquisition ScanProcedure: Computed TomographyProcedure: Positron Emission TomographyProcedure: Lumbar PunctureProcedure: Bone Marrow AspirationProcedure: Bone Marrow BiopsyProcedure: Biospecimen CollectionProcedure: Biopsy
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT05936229
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Remotely Delivered, Culturally Tailored Weight Loss Interventions Among Latina Breast Cancer Survivors
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- Behavioral: Behavioral InterventionProcedure: Biospecimen CollectionBehavioral: Behavioral Dietary InterventionOther: Health Promotion and EducationOther: Dietary InterventionOther: Educational InterventionOther: Exercise InterventionOther: Internet-Based InterventionOther: InterviewBehavioral: Lifestyle CounselingOther: Medical Device Usage and EvaluationOther: Nutritional InterventionOther: Questionnaire AdministrationBehavioral: Telephone-Based Intervention
- First Posted Date
- 2023-07-05
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 620
- Registration Number
- NCT05930483
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors
- First Posted Date
- 2023-07-05
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05930496
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 61
- Registration Number
- NCT05897242
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-05-24
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT05874297
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Avatar-Led Digital Therapeutic for Aiding Smoking Cessation in Sexual and Gender Minority Young Adults
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-05-08
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 125
- Registration Number
- NCT05847673
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
© Copyright 2024. All Rights Reserved by MedPath